Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1769, ahead of CRISPR Therapeutics (1112) and Kymera Therapeutics (265). Figures as of 18 Nov 2026, 20:43 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1769
Median
14.3
Combined market value
DKK 5.71T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
DKK
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1769DKK 48.7BDKK 544.88 1.37% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1112DKK 26.6BDKK 274.08 0.25% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care265DKK 70.7BDKK 828.08 0.07% up 87% up United States
4ImmunityBioIBRX · Health Care63.0DKK 48.6BDKK 45.69 7.19% up 193% up United States
5ModernaMRNA · Health Care41.2DKK 545.2BDKK 1,347.33 4.32% down 755% up United States
6Krystal BiotechKRYS · Health Care24.0DKK 63.6BDKK 2,147.63 5.64% up 46% up United States
7Twist BioscienceTWST · Health Care21.0DKK 53.8BDKK 789.54 3.53% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.6DKK 31.3BDKK 193.59 0.21% down 88% up United States
9RepligenRGEN · Health Care15.0DKK 75.4BDKK 1,179.68 6.82% up 5% up United States
10argenxARGX · Health Care14.3DKK 403.7BDKK 6,419.28 0.51% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4DKK 77.9BDKK 495.65 0.22% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.8DKK 74.5BDKK 653.35 0.02% down 37% up United States
13ExelixisEXEL · Health Care7.2DKK 113.9BDKK 466.64 0.04% up 63% up United States
14Gilead SciencesGILD · Health Care7.1DKK 1.43TDKK 1,153.77 0.48% down 33% up United States
15AmgenAMGN · Health Care6.5DKK 1.64TDKK 3,028.02 2.89% down 34% up United States
16BioNTechBNTX · Health Care6.5DKK 141.1BDKK 569.05 1.52% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.8DKK 112.1BDKK 1,107.26 1.99% down 20% up United States
18QiagenQGEN · Health Care4.9DKK 69.8BDKK 338.15 0.18% down 12% up Netherlands
19BiogenBIIB · Health Care3.7DKK 252.3BDKK 1,706.79 0.05% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8093 DKK). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1769), CRISPR Therapeutics (1112) and Kymera Therapeutics (265) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 20:43 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of DKK 5.71T as of 18 Nov 2026, 20:43 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.